Bronchiectasis is a heterogeneous condition and may be encountered as a stand-alone pulmonary disease by primary care clinicians and specialists in pulmonary medicine. Bronchiectasis sometimes ...

Bronchiectasis is a condition where the bronchial tubes of your lungs are permanently damaged, widened, and thickened. These damaged air passages allow bacteria and mucus to build up and pool in your ...

Bronchiectasis is a lung condition that causes a persistent cough and excess phlegm, or sputum. It is a permanent condition that gets worse over time. It can be fatal. The bronchi dilate, usually ...

The ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% compared with placebo. Brensocatib is a DPP-1 inhibitor that works by reducing ...

Patients with bronchiectasis recovering from severe COVID-19 face higher risks of exacerbation and mortality compared to nonsevere cases. The study utilized data from Korea's National Health Insurance ...

We found no new evidence that affects the recommendations. For more information, see the surveillance decision. This guideline updates and replaces NICE evidence summaries ESUOM25, ESUOM38 and ES12.